Mechanism of anticonvulsant action of valproate

A Chapman, PE Keane, BS Meldrum, J Simiand… - Progress in …, 1982 - Elsevier
3, Clinical use of valproate 317 3.1. Epilepsy 317 3.1. 1. Primary generalised seizures 317
3.1. 2. Partial seizures 319 3.1. 3. Status epilepticus 319 3.1. 4. Prophylaxis of febrile …

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of …

G Griebel, J Simiand… - Proceedings of the …, 2002 - National Acad Sciences
The limbic localization of the arginine vasopressin V 1b receptor has prompted speculation
as to a potential role of this receptor in the control of emotional processes. To investigate this …

Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks

…, J Simiand, M Morre, RH Dodd, J Rossier - Nature, 1986 - nature.com
Benzodiazepines are widely used anxiolytics and anticonvulsants, and their potent sedative
properties are routinely used in presurgical anaesthesia. However, they are also known to …

SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset

J Simiand, M Keane, PE Keane… - Behavioural …, 1998 - journals.lww.com
SR 141716 (1 and 3 mg/kg po), a selective central (CB1) cannabinoid receptor antagonist,
selectively reduced feeding of a very highly palatable cane-sugar mixture in marmosets. In …

The vasopressin V1b receptor as a therapeutic target in stress-related disorders

G Griebel, J Simiand, J Stemmelin… - Current Drug Targets …, 2003 - ingentaconnect.com
The complexity of the stress response would appear to provide multiple opportunities for
intervention, but treatment strategies are often centered on the improvement of symptoms rather …

Characterization of (2S, 4R)-1-[5-chloro-1-[(2, 4-dimethoxyphenyl) sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2, 3-dihydro-1H-indol-3-yl]-4-hydroxy-N, N-dimethyl-2 …

C Serradeil-Le Gal, J Wagnon, J Simiand… - … of Pharmacology and …, 2002 - ASPET
(2S,4R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine
carboxamide (SSR149415), the first …

SL651498, a GABAA Receptor Agonist with Subtype‐Selective Efficacy, as a Potential Treatment for Generalized Anxiety Disorder and Muscle Spasms

G Griebel, G Perrault, J Simiand, C Cohen… - CNS drug …, 2003 - Wiley Online Library
SL651498 (6‐fluoro‐9‐methyl‐2‐phenyl‐4‐(pyrrolidin‐1‐yl‐carbonyl)‐2, 9‐dihydro‐1H‐pyrido[3,4‐b]indol‐1‐one)
was identified as a drug development candidate from a research …

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl) ethyl] 5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride …

G Griebel, J Simiand, R Steinberg, M Jung… - … of Pharmacology and …, 2002 - ASPET
The present study investigated the effects of the novel corticotrophin-releasing factor (CRF)
1 receptor antagonist 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-…

The staircase test in mice: a simple and efficient procedure for primary screening of anxiolytic agents

J Simiand, PE Keane, M Morre - Psychopharmacology, 1984 - Springer
The staircase test consists of placing a naive mouse in an enclosed staircase with five steps
and observing the number of steps climbed and rearings made in a 3-min period. All the …

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.

…, C Congy, V Santucci, J Simiand… - … of Pharmacology and …, 1992 - ASPET
A new potent, selective and po active serotonergic [5-hydroxytryptamine (5-HT2)] receptor
antagonist, SR 46349B [trans, 4-([3Z)3-(2-dimethylaminoethyl)oxyimino-3(2-flurophenyl++ +)…